CMS AHA Asks for Investigation Into MA Organizations Over Prior Authorization… Thomas Sullivan Jun 30, 2022 0 The American Hospital Association has asked the Department of Justice (DOJ) and Centers for Medicare & Medicaid Services (CMS)…
CME California Senate Passes Legislation to Require CME for Physicians Covering… Thomas Sullivan Jun 29, 2022 0 Recently, the California Senate passed Senate Bill 923, the TGI Inclusive Care Act, by a vote of 28-6. The legislation – the first…
CME FDA Launches Educational Initiative About Supplements Thomas Sullivan Jun 28, 2022 0 On June 2, 2022, the United States Food and Drug Administration (FDA) announced a new initiative, Supplement Your Knowledge. The…
State Policy Connecticut to Establish a Permanent Rare Disease Advisory Council Thomas Sullivan Jun 27, 2022 0 In May 2022, Connecticut Governor Ned Lamont signed House Bill 5500 into law, which will help establish a permanent Rare Disease…
Compliance Policy and Medicine Compliance Update – June 2022 Issue: Explores Role of… Thomas Sullivan Jun 24, 2022 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
CME Translating Clinical Research to Clinical Care in Nephrology Thomas Sullivan Jun 24, 2022 0 Recently, CMEology conducted a study of nephrologists to identify factors that are influential in the translation of research…
Congress Legislation Focused on Revamping MA Prior Authorization Hits Important… Thomas Sullivan Jun 23, 2022 0 In mid-May 2022, H.R. 3173, the Improving Seniors’ Timely Access to Care Act of 2021 surpassed the 290-cosponsor threshold needed…
Congress Attention on March-In Rights – What Are They and Why are they Relevant? Thomas Sullivan Jun 22, 2022 0 March-in rights are rights granted to the federal government, allowing the government the ability to grant patent licenses to…
DOJ DaVita and Former CEO Acquitted on Conspiracy Charges Thomas Sullivan Jun 21, 2022 0 Earlier this year, a Colorado jury acquitted DaVita and its former CEO Kent Thiry on charges that they conspired with competitors…
FDA OPDP to Study Product Claims in DTC and HCP Promotions Thomas Sullivan Jun 20, 2022 0 Earlier this year, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) published a…